SMITH & WESSON BRANDS, INC. (SWBI) stock intrinsic value fair value estimate & owner earnings analysis

Smith & Wesson Brands makes handguns and long guns under the Smith & Wesson and Gemtech brands, manufactured at plants in Maryville, Tennessee; Springfield, Massachusetts; and Houlton, Maine. It is one of the largest handgun makers in the United States, selling mostly through the traditional sporting-goods distribution channel with a smaller law-enforcement/professional channel. The company as it exists today dates to August 2020, when the old American Outdoor Brands Corporation split into two independent public companies: the outdoor-accessories business went one way, and the firearms business was renamed Smith & Wesson Brands and kept the stock ticker and this filing history. Because that earlier combined company was a meaningfully different, larger business, this valuation is built entirely from the results Smith & Wesson has reported since that split -- six full fiscal years (2021 through 2026) -- rather than blending in the years before it. Those six years tell a boom-and-bust story typical of the firearms industry: sales spiked to roughly $1.06 billion in fiscal 2021 amid a historic surge in demand, stayed elevated in fiscal 2022, then fell back sharply to roughly $475-536 million a year in fiscal 2023 through 2025 as the industry worked through excess inventory. Fiscal 2026 sales grew again, to about $524 million, and importantly this recovery was driven by the company's own execution -- newly introduced handgun models made up over 40% of handgun sales for the year, and a modest price increase took effect -- even though overall industry demand (measured by national background-check volume) was roughly flat. That is a meaningfully different, more durable kind of growth than simply riding a demand panic, and it is the main reason to expect the business to grow at all from here. Set against that, the company has been absorbing higher costs from U.S. tariffs on imported components and materials, which is one reason profit margins have not recovered to their pre-2023 level even as sales have picked up; the company has said this pressure may continue and its resolution is uncertain. Separately, the company spent heavily (roughly $90 million a year in fiscal 2023 and 2024) building a large new manufacturing campus in Tennessee. That spending is now largely behind it, but the company's own guidance for the coming year calls for capital spending of $40-45 million annually -- well above the roughly $22-24 million a year it spent before and after the construction project -- which suggests the ongoing cost of running and continuously retooling the business for new products is now structurally higher than it used to be. This valuation treats that near-term guided spending level as real, then assumes it eases toward a still-elevated $30 million a year rather than falling all the way back to the old level, because there is no specific evidence yet that it will. The business carries a very light debt load and pays a regular quarterly dividend. Legal matters on file are fairly routine for a manufacturer of this kind -- a handful of ongoing product-liability claims, and a long-running contract dispute over an earlier acquisition (Gemtech) that is set for trial in January 2027, where the company believes the claim has no merit and has already had the more serious allegations dismissed. Given all of that, three cases were built. In the base case, share gains from new products continue at a more moderate pace than the exceptional 2026 showing, tariff-related cost pressure persists without disappearing, and capital spending eases only partway back down; on those assumptions, the shares are worth on the order of $14. In a bull case, the recent pattern of new products winning share continues for several more years, pricing power holds, and some of the tariff pressure eases -- worth on the order of $24-25, still well short of the 2021 boom-year revenue level, because that case is built from the company's own demonstrated execution rather than a hoped-for repeat of a demand panic. In a bear case, demand settles back at the low end of what the industry has actually shown it can fall to in the last few cycles, tariff costs are not offset, and capital spending stays at the elevated guided level indefinitely with a modest charge from the pending litigation -- in that case the business is worth close to nothing, and by our math is worth slightly less than zero per share once that combination is assumed to persist. That reflects how thin margins get in this industry's troughs and how much of the profit a sustained higher level of capital spending would absorb, not any expectation of bankruptcy or a going-concern problem, which nothing here indicates. Because the gap between the bear and base outcomes is unusually wide -- a hallmark of this industry's demand swings -- the margin-of-safety price sits at a meaningful discount to the base-case estimate, on the order of $7 per share. Evidence that gross margins have stabilized above roughly 28% or that capital spending has settled below roughly $30 million a year would be signs that the current cost pressure and investment cycle have genuinely passed, which would support a value closer to the base-case estimate itself.